These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
345 related items for PubMed ID: 25661675
1. Comparison of intermittent and continuous extracorporeal treatments for the enhanced elimination of dabigatran. Bouchard J, Ghannoum M, Bernier-Jean A, Williamson D, Kershaw G, Weatherburn C, Eris JM, Tran H, Patel JP, Roberts DM. Clin Toxicol (Phila); 2015 Mar; 53(3):156-63. PubMed ID: 25661675 [Abstract] [Full Text] [Related]
2. Hemodialysis for the treatment of pulmonary hemorrhage from dabigatran overdose. Chen BC, Sheth NR, Dadzie KA, Smith SW, Nelson LS, Hoffman RS, Winchester JF. Am J Kidney Dis; 2013 Sep; 62(3):591-4. PubMed ID: 23597859 [Abstract] [Full Text] [Related]
3. Extracorporeal therapy for dabigatran removal in the treatment of acute bleeding: a single center experience. Singh T, Maw TT, Henry BL, Pastor-Soler NM, Unruh ML, Hallows KR, Nolin TD. Clin J Am Soc Nephrol; 2013 Sep; 8(9):1533-9. PubMed ID: 23704302 [Abstract] [Full Text] [Related]
4. [The effects of continuous renal replacement therapy (CRRT) and intermittent haemodialysis (IHD) in the treatment of dabigatran overdose. Case report]. Vitale C, Berutti S, Montaruli B, Cosseddu D, Sivera P, Verdecchia C, Migliardi M, Marangella M. G Ital Nefrol; 2014 Sep; 31(2):. PubMed ID: 24777926 [Abstract] [Full Text] [Related]
5. Effective elimination of dabigatran by haemodialysis. A phase I single-centre study in patients with end-stage renal disease. Khadzhynov D, Wagner F, Formella S, Wiegert E, Moschetti V, Slowinski T, Neumayer HH, Liesenfeld KH, Lehr T, Härtter S, Friedman J, Peters H, Clemens A. Thromb Haemost; 2013 Apr; 109(4):596-605. PubMed ID: 23389759 [Abstract] [Full Text] [Related]
6. Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP) - March 2013. Pernod G, Albaladejo P, Godier A, Samama CM, Susen S, Gruel Y, Blais N, Fontana P, Cohen A, Llau JV, Rosencher N, Schved JF, de Maistre E, Samama MM, Mismetti P, Sié P, Working Group on Perioperative Haemostasis. Arch Cardiovasc Dis; 2013 Apr; 106(6-7):382-93. PubMed ID: 23810130 [Abstract] [Full Text] [Related]
7. Removal of dabigatran by hemodialysis. Chang DN, Dager WE, Chin AI. Am J Kidney Dis; 2013 Mar; 61(3):487-9. PubMed ID: 23219111 [Abstract] [Full Text] [Related]
8. [Vaginal bleeding as symptom of a medical emergency--pitfalls of therapy with new oral anticoagulants - case 5/2014]. Baumann D, Haap M, Tsaousidis C, Krämer B, Schreieck J, Jaschonek K, Rettig I, Peter A, Wallwiener D, Artunc F. Dtsch Med Wochenschr; 2014 Jul; 139(30):1539. PubMed ID: 25072863 [Abstract] [Full Text] [Related]
9. Intermittent haemodialysis and continuous veno-venous dialysis are effective in mitigating major bleeding due to dabigatran. Getta B, Muller N, Motum P, Hsu D, Zebeljan D, Rosenfeld D. Br J Haematol; 2015 May; 169(4):603-4. PubMed ID: 25425051 [No Abstract] [Full Text] [Related]
10. Life-threatening bleeding in four patients with an unusual excessive response to dabigatran: implications for emergency surgery and resuscitation. Lillo-Le Louët A, Wolf M, Soufir L, Galbois A, Dumenil AS, Offenstadt G, Samama MM. Thromb Haemost; 2012 Sep; 108(3):583-5. PubMed ID: 22782645 [No Abstract] [Full Text] [Related]
11. Dabigatran and kidney disease: a bad combination. Knauf F, Chaknos CM, Berns JS, Perazella MA. Clin J Am Soc Nephrol; 2013 Sep; 8(9):1591-7. PubMed ID: 23868901 [Abstract] [Full Text] [Related]
12. Hemodialysis for the treatment of dabigatran-associated bleeding: a case report and systematic review. Chai-Adisaksopha C, Hillis C, Lim W, Boonyawat K, Moffat K, Crowther M. J Thromb Haemost; 2015 Oct; 13(10):1790-8. PubMed ID: 26270886 [Abstract] [Full Text] [Related]
13. Measurement of dabigatran in standardly used clinical assays, whole blood viscoelastic coagulation, and thrombin generation assays. van Ryn J, Grottke O, Spronk H. Clin Lab Med; 2014 Sep; 34(3):479-501. PubMed ID: 25168938 [Abstract] [Full Text] [Related]
15. Bleeding events and activated partial thromboplastin time with dabigatran in clinical practice. Kawabata M, Yokoyama Y, Sasano T, Hachiya H, Tanaka Y, Yagishita A, Sugiyama K, Nakamura T, Suzuki M, Isobe M, Hirao K. J Cardiol; 2013 Aug; 62(2):121-6. PubMed ID: 23680005 [Abstract] [Full Text] [Related]
16. Enhanced elimination of dabigatran: Identifying the appropriate patient for the use of continuous venovenous hemodialysis instead of intermittent hemodialysis-A simulation analysis. Liesenfeld KH, Gruenenfelder F, Clemens A. J Clin Pharmacol; 2016 May; 56(5):597-608. PubMed ID: 26272714 [Abstract] [Full Text] [Related]
17. [Hemodialysis to remove anticoagulant dabigatran during emergencies]. Carrizo A, Campbell S. Medicina (B Aires); 2014 May; 74(2):121-3. PubMed ID: 24736256 [Abstract] [Full Text] [Related]
18. Management and outcomes of major bleeding during treatment with dabigatran or warfarin. Majeed A, Hwang HG, Connolly SJ, Eikelboom JW, Ezekowitz MD, Wallentin L, Brueckmann M, Fraessdorf M, Yusuf S, Schulman S. Circulation; 2013 Nov 19; 128(21):2325-32. PubMed ID: 24081972 [Abstract] [Full Text] [Related]
19. Dabigatran-induced gastrointestinal bleeding in an elderly patient with moderate renal impairment. Wychowski MK, Kouides PA. Ann Pharmacother; 2012 Apr 19; 46(4):e10. PubMed ID: 22496474 [Abstract] [Full Text] [Related]
20. Impaired renal function and bleeding in elderly treated with dabigatran. Berthelot E, Lavenu-Bombled C, Orostegui-Giron L, Desconclois C, Assayag P. Blood Coagul Fibrinolysis; 2014 Sep 19; 25(6):618-20. PubMed ID: 24509332 [Abstract] [Full Text] [Related] Page: [Next] [New Search]